# NextRNA Therapeutics, Inc. — Form D

NextRNA Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-01-27. The offering totals $50.0M, of which $23.4M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2022-01-27
- Form: D
- Accession: 0001907060-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $50.0M
- Amount sold: $23.4M
- Remaining: $26.6M
- Investors: 34
- Date of first sale: 2022-01-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-431048

## Issuer

- Name: NextRNA Therapeutics, Inc.
- CIK: 0001907060
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: C/O IPSEN BIOLABS, CAMBRIDGE, MA, 02142
- Phone: 617-412-6117

## Officers, directors & promoters (16)

| Name | Role | Location |
| --- | --- | --- |
| Kenneth A Anderson | Director | Cambridge, MA |
| Andrea A Armstrong | Director | Cambridge, MA |
| Arthur A Becker | Director | Cambridge, MA |
| Alain A Cohen | Director | Cambridge, MA |
| Marc A Cohen | Director | Cambridge, MA |
| Drew A Dennison | Director | Cambridge, MA |
| Christine A Henderson | Director | Cambridge, MA |
| Susan A Langer | Director | Cambridge, MA |
| Fred A Mermelstein | Director | Cambridge, MA |
| Carl A Novina | Director | Andover, MA |
| Barry A Polisky | Director | Andover, MA |
| Elena A Prokupets | Director | Cambridge, MA |
| Malcolm A Salter | Director | Cambridge, MA |
| Dominique A Verhelle | Director | Cambridge, MA |
| Marc A Cohen | Executive Officer | Cambridge, MA |
| Julia A Novina | Executive Officer | Boston, MA |

## More

- [CIK 1907060 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1907060&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001907060-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.